Skip to main content
Retour
MBX logo

MBX Biosciences, Inc. Common Stock

Qualité des données : 100%
MBX
NASDAQ Healthcare Biotechnology
28,14 €
▼ 0,54 € (-1,88%)
Cap. Boursière : 945,31M
Fourchette du Jour
28,05 € 29,88 €
Fourchette 52 Semaines
4,81 € 44,89 €
Volume
538 872
Moyenne 50J / 200J
35,10 € / 22,42 €
Clôture Précédente
28,68 €

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (626 pairs)

Métrique Action Médiane du Secteur
P/E -10,9 0,4
P/B 2,6 2,9
ROE % -27,8 3,7
Net Margin % 3,8
Rev Growth 5Y % 10,0
D/E 0,0 0,2

Points Clés

Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -81,88M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-27,76%
ROIC-19,89%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
0,00
Current Ratio24,62
Interest Coverage0,00

Valorisation

P/E Ratio
-10,87
P/B Ratio2,56
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -86,97M
ROE -27,76% ROA -22,58%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -81,88M
ROIC -19,89% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,00 Current Ratio 24,62
Interest Coverage 0,00 Dividend Yield 0,00%
Valuation
P/E Ratio -10,87 P/B Ratio 2,56
P/S Ratio N/A PEG Ratio -0,46
EV/EBITDA N/A Dividend Yield 0,00%
Market Cap 945,31M Enterprise Value 870,62M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue 0,0 0,0 0,0 0,0
Net Income -86,97M -61,92M -32,56M -26,14M
EPS (Diluted) -2,38 -1,85 -1,02 -0,82
Gross Profit -248 000,0 0,0 0,0 0,0
Operating Income -98,06M -68,19M -35,31M -25,16M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 385,14M 268,54M 84,18M 45,10M
Total Liabilities 15,92M 11,09M 156,65M 87,70M
Shareholders' Equity 369,22M 257,44M -72,47M -42,61M
Total Debt 596 000,0 171 000,0 324 000,0 461 000,0
Cash & Equivalents 75,29M 49,35M 30,52M 24,21M
Current Assets 381,54M 267,29M 83,47M 44,21M
Current Liabilities 15,50M 11,05M 3,93M 3,43M